Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Active Comparator: Morphine

Phase 3Small molecule

SShanghai Haiyan Pharmaceutical Technology Co., Ltd.

1

Indications

2

Total Trials

1

Active Trials

0

Competitors

Timeline

Expected Milestones

Q3 2026

Phase 3Active, not recruiting

Pain

NCT06890533

Clinical

Trials by Indication[1]

Pain2 trials

A Phase Ⅲ, Randomized, Double-Blind, Placebo- and Active-controlled Study of YZJ-4729 Tartrate Injection for the Treatment of Moderate to Severe Pain After Abdominal Surgery

Active, not recruiting·SShanghai Haiyan Pharmaceutical Technology Co., Ltd.·Phase 3·NCT06890533·560 enrolled

A PhaseⅡ, Randomized, Double-Blind, Placebo- and Active- Controlled Study of YZJ-4729 Tartrate Injection for the Treatment of Moderate to Severe Pain After Orthopedic Surgery

Completed·SShanghai Haiyan Pharmaceutical Technology Co., Ltd.·Phase 2·NCT06901830·150 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Active Comparator: Morphine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Active Comparator: Morphine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Active Comparator: Morphine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Shanghai Haiyan Pharmaceutical Technology Co., Ltd. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: SShanghai Haiyan Pharmaceutical Technology Co., Ltd.

Related News